메뉴 건너뛰기




Volumn 93, Issue 4, 2009, Pages 468-473

Observational prospective study of the effectiveness in routine clinical practice of verteporfin photodynamic therapy in patients with neovascular age-related macular degeneration

Author keywords

[No Author keywords available]

Indexed keywords

VERTEPORFIN;

EID: 64849102034     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2008.141366     Document Type: Article
Times cited : (4)

References (14)
  • 1
    • 0026681119 scopus 로고
    • Prevalence of age-related maculopathy: The Beaver Dam Eye Study
    • Klein R, Klein BE, Linton KL. Prevalence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 1992;99:933- 43.
    • (1992) Ophthalmology , vol.99 , pp. 933-943
    • Klein, R.1    Klein, B.E.2    Linton, K.L.3
  • 2
    • 0028839002 scopus 로고
    • The prevalence of age-related maculopathy in the Rotterdam study
    • Vingerling JR, Dielemans I, Hofman A, et al. The prevalence of age-related maculopathy in the Rotterdam study. Ophthalmology 1995;102:205-10.
    • (1995) Ophthalmology , vol.102 , pp. 205-210
    • Vingerling, J.R.1    Dielemans, I.2    Hofman, A.3
  • 4
    • 0342632445 scopus 로고    scopus 로고
    • Photodynamic therapy of subfoveal choroidal neovascularisation in age-related macular degeneration with verteporfin: One-year results of 2 randomised clinical trials. TAP
    • TAP study group
    • TAP study group. Photodynamic therapy of subfoveal choroidal neovascularisation in age-related macular degeneration with verteporfin: one-year results of 2 randomised clinical trials. TAP report 1. Arch Ophthalmol 1999;117:1239-45.
    • (1999) Arch Ophthalmol , vol.117 , pp. 1239-1245
  • 5
    • 0035124965 scopus 로고    scopus 로고
    • Photodynamic therapy of subfoveal choroidal neovascularisation in age-related macular degeneration with verteporfin: Two-year results of 2 randomised clinical trials. TAP
    • TAP study group
    • TAP study group. Photodynamic therapy of subfoveal choroidal neovascularisation in age-related macular degeneration with verteporfin: two-year results of 2 randomised clinical trials. TAP report 2. Arch Ophthalmol 2001;119:198-207.
    • (2001) Arch Ophthalmol , vol.119 , pp. 198-207
  • 6
    • 33749445317 scopus 로고    scopus 로고
    • Ranibizumab for neovascular age-related macular degeneration
    • Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006;355:1419-31.
    • (2006) N Engl J Med , vol.355 , pp. 1419-1431
    • Rosenfeld, P.J.1    Brown, D.M.2    Heier, J.S.3
  • 7
    • 33749451356 scopus 로고    scopus 로고
    • Ranibizumab versus verteporfin for neovascular age-related macular degeneration
    • Brown DM, Kaiser PK, Michels M, et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 2006;355:1432-44.
    • (2006) N Engl J Med , vol.355 , pp. 1432-1444
    • Brown, D.M.1    Kaiser, P.K.2    Michels, M.3
  • 8
    • 11144239923 scopus 로고    scopus 로고
    • Pegaptanib for neovascular age-related macular degeneration
    • Gragoudas ES, Adamis AP, Cunningham ET Jr, et al. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 2004;351:2805-16.
    • (2004) N Engl J Med , vol.351 , pp. 2805-2816
    • Gragoudas, E.S.1    Adamis, A.P.2    Cunningham Jr, E.T.3
  • 10
    • 0025736267 scopus 로고
    • Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics: ETDRS
    • Early Treatment Diabetic Retinopathy Study Research Group
    • Early Treatment Diabetic Retinopathy Study Research Group. Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics: ETDRS Report Number 7. Ophthalmology 1991;98:741-56.
    • (1991) Ophthalmology , vol.98 , pp. 741-756
  • 11
    • 0020027985 scopus 로고
    • Macular Photocoagulation Study. Argon laser photocoagulation for senile macular degeneration. Results of a randomized clinical trial
    • Macular Photocoagulation Study. Argon laser photocoagulation for senile macular degeneration. Results of a randomized clinical trial. Arch Ophthamol 1982;100:912-18.
    • (1982) Arch Ophthamol , vol.100 , pp. 912-918
  • 12
    • 0034018598 scopus 로고    scopus 로고
    • Macular degeneration: Do conventional measurements of impaired vision equate with visual disability?
    • McClure ME, Hart PM, Jackson AJ, et al. Macular degeneration: do conventional measurements of impaired vision equate with visual disability? Br J Ophthalmol 2000;84:244-50.
    • (2000) Br J Ophthalmol , vol.84 , pp. 244-250
    • McClure, M.E.1    Hart, P.M.2    Jackson, A.J.3
  • 13
    • 0036822175 scopus 로고    scopus 로고
    • Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: Three-year results of an open-label extension of 2 randomized clinical trials-TAP Report no. 5
    • TAP Study Group
    • TAP Study Group. Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: three-year results of an open-label extension of 2 randomized clinical trials-TAP Report no. 5. Arch Ophthalmol 2002;120:1307-14.
    • (2002) Arch Ophthalmol , vol.120 , pp. 1307-1314
  • 14
    • 4344583798 scopus 로고    scopus 로고
    • Cost effectiveness of photodynamic therapy with verteporfin for age related macular degeneration: The UK case
    • Smith DH, Fenn P, Drummond M. Cost effectiveness of photodynamic therapy with verteporfin for age related macular degeneration: the UK case. Br J Ophthalmol 2004;88:1107-12.
    • (2004) Br J Ophthalmol , vol.88 , pp. 1107-1112
    • Smith, D.H.1    Fenn, P.2    Drummond, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.